首页> 外文期刊>Journal of otolaryngology - head & neck surgery = >Retrospective review of three antiemetic regimens versus no therapy in the prevention of postoperative and vomiting following adenotonsillar surgery
【24h】

Retrospective review of three antiemetic regimens versus no therapy in the prevention of postoperative and vomiting following adenotonsillar surgery

机译:回顾性分析三种止吐方案与无疗法在腺扁桃体手术后预防术后呕吐的效果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: To study the effect of intraoperative ondansetron and dexamethasone on postoperative vomiting in children undergoing tonsillectomy, adenotonsillectomy, or adenoidectomy. Study Design: Retrospective chart review. Setting: Academic tertiary care referral centre in the west of Scotland. Subjects and Methods: A retrospective chart review was conducted on 432 children admitted to our institute between 2004 and 2006. Of these, 285 (66%) patients underwent a tonsillectomy, 50 (11.6%) an adenotonsillectomy, and 97 (22.4%) an adenoidectomy. There was an equal gender distribution, with a mean age of 7.4 years (interquartile range 4.6-10.0). Patients were divided into four groups: group 1 received ondansetron plus dexamethasone (n = 64, 14.7%), group 2 received ondansetron only (n = 189, 43.6%), group 3 received dexamethasone only (n = 17, 3.9%), and group 4 did not receive ondansetron or dexamethasone (n = 162, 37.4%). Results: Overall, 98 (22.7%) patients experienced postoperative vomiting (5 at the time of recovery and 93 on the ward). Patients in group 1 had a significantly lower incidence of postoperative vomiting than those in group 2 (10.9% vs 22.8%, p = .04) and group 4 (10.9% vs 27.2%, p < .01). The incidence of postoperative vomiting was also lower in group 1 than in group 3, but this did not reach statistical significance (10.9% vs 23.5%, p = .18). Conclusion: The combined intraoperative use of ondansetron and dexamethasone appears to be superior to no antiemetic or ondansetron alone in reducing the incidence of vomiting in children undergoing adenotonsillar surgery.
机译:目的:探讨术中恩丹西酮和地塞米松对扁桃体切除,腺扁桃体切除或腺样体切除术患儿术后呕吐的影响。研究设计:回顾性图表审查。地点:苏格兰西部的三级学术转诊中心。研究对象和方法:对2004年至2006年间入院的432名儿童进行了回顾性图表审查。其中,有285例(66%)接受扁桃体切除术,50例(11.6%)腺扁桃体切除术和97例(22.4%)腺样体切除术。性别分布均匀,平均年龄为7.4岁(四分位间距为4.6-10.0)。患者分为四组:第一组接受恩丹西酮加地塞米松(n = 64,14.7%),第二组仅接受恩丹西酮(n = 189,43.6%),第三组仅接受地塞米松(n = 17,3.9%),第4组未接受恩丹西酮或地塞米松(n = 162,37.4%)。结果:总体而言,98例患者(22.7%)经历了术后呕吐(康复时5例,病房93例)。第1组患者的术后呕吐发生率明显低于第2组(10.9%vs 22.8%,p = .04)和第4组(10.9%vs 27.2%,p <.01)。第1组的术后呕吐发生率也低于第3组,但这没有统计学意义(10.9%vs 23.5%,p = .18)。结论:在减少接受腺扁桃体手术的儿童的呕吐发生率方面,在术中联合使用昂丹司琼和地塞米松似乎优于不使用止吐药或单独使用昂丹司酮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号